The mRNA-based reprogramming of fibroblasts from a SOD1E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007


Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1E101G mutation. Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Authors Balez R, Berg T, Bax M, Muñoz SS, Cabral-da-Silva MC, Engel M, Do-Ha D, Stevens CH, Rowe D, Yang S, Blair IP, Ooi L
Journal Stem cell research
Publication Date 2020 Jan;42:101701
PubMed 32006803
DOI 10.1016/j.scr.2020.101701

Research Projects

Cell Lines